Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Sales | 1,200 | 950 | 1,400 | 1,650 | 1,520 |
| Cost of Goods | 4,060 | 0 | 0 | 0 | 0 |
| Gross Profit | -2,850 | 950 | 1,400 | 1,650 | 1,520 |
| Operating Expenses | 1,284 | 5,231 | 4,520 | 4,520 | 4,049 |
| Operating Income | -4,084 | -4,281 | -3,120 | -2,870 | -2,529 |
| Other Income | 454 | 141 | -110 | -80 | 229 |
| Pre-tax Income | -3,630 | -4,140 | -3,230 | -2,950 | -2,300 |
| Net Income Continuous | -3,630 | -4,140 | -3,230 | -2,950 | -2,300 |
| Net Income | $-3,630 | $-4,140 | $-3,230 | $-2,950 | $-2,300 |
| EBITDA(a) | $-3,784 | $-4,011 | $-2,830 | $-2,620 | $-2,289 |